Brevi-T's groundbreaking rapid-response system, makes it possible to quickly detect pathogens – including new variants - saving lives and making the world a healthier place.
SAN DIEGO, Dec. 13, 2022 /PRNewswire-PRWeb/ -- Brevi-T is pleased to announce its groundbreaking rapid-response tracking system, making it possible to quickly detect pathogens – including new variants – via wastewater, surface swiping, or nasal swab testing.
Infectious diseases travel faster and farther than ever before. New and re-emerging diseases can quickly spread, resulting in deadly outbreaks that overwhelm health systems, jeopardize lives, and threaten societies. Rapidly monitoring the movement of pathogens in a community is essential for preventing and controlling the spread of disease.
Brevi-T has created a single source solution and action plan for public health management, including wastewater tests and individual tests for at-large upper respiratory infections. The results are integrated with real-time environmental, demographic, and health data in a centralized platform, called PULSE, to identify patterns, predict trends, and provide vital context to public health authorities.
Wastewater surveillance is a proven, efficient way to detect community disease levels, potentially identifying outbreaks much sooner than clinical testing, which enables a more rapid health response. It is non-invasive and reduces the need for unnecessary and costly individual testing.
Brevi-T's highly specialized approach solves the problems that hamper the most effective and efficient use of wastewater testing: the lack of a centralized current database and standardized collection and testing methods. By integrating up-to-date environmental demographic information, Brevi-T can aggregate, interpret, and compare real-time data across locations to help accelerate public health interventions by enabling users to swiftly implement the best action plan to provide maximum protection.
"Our design enables detection of all common URI pathogens. It includes current URI viruses (i.e., Pan Flu A & B, Pan Coronavirus) and it can detect new corona and influenza viruses. We contextualize findings locally and globally, to provide trends and predictions. Digital and mobile applications integrate remote field results with our centralized database and send automatic alerts, enabling public safety assessment and epidemiology in real time through regional and global awareness." – Corina Shtir, PhD, CEO Brevi-T Bio
The PULSE secure responsive monitoring and prediction platform uses state-of-the-art cloud-based software to integrate automated wastewater testing, individual swab testing (if required), data enrichment, advanced analytics, rapid reporting, and a real-time alert system to deliver accurate pathogen prevalence results. Its customizable dashboard interface is uniquely user-friendly and presents essential information clearly and accessibly, allowing users with no technical experience to easily access and understand it, enabling them to move faster and more confidently to develop action plans.
Additionally, PULSE provides full sample process management and logistics through its mobile apps, which are critically important for identifying factors that may influence outcomes and eventual false positives or negatives. PULSE makes it possible to monitor entire communities and regions rapidly, accurately, and cost-effectively for both existing and emerging pathogens.
"The pandemic has made us all aware that infectious disease surveillance in wastewater is a cost-effective and early warning tool for outbreaks and trends in the human population. What Brevit-T adds to this environment is the ability to track trends on a granularized basis, focusing on the specific wastewater coming from different parts of the community, and not just at the treatment facility level." – Paul Scott, CTO Brevi-T Bio
This first-of-its kind combination of consistent process management, real-time data, and cutting-edge analytics makes it possible to compare local, regional, and global trends which, in turn, allows for the prediction of future patterns and control of disease outbreaks, saving lives and making the world a healthier place.
About Brevi-T - https://brevitbio.com/
Brevi-T, a joint venture between InterOme, a digital health enterprise, and Avrok Biosciences is tackling some of the world's biggest public health challenges, including infectious diseases, substance abuse, and environmental contaminants through improved practices, plans and policies. Brevi-T's mission is to make the world a healthier place, by creating the means to detect, assess, and manage public health risk factors to prevent the spread of epidemics. BreviT's goal is to use actionable data for the best possible individual and public health outcomes.
Media Contact
Corina Shtir, Brevi-T Bio, 1 858-294-0204, [email protected]
SOURCE Brevi-T Bio
Share this article